Organigram to post Q2 2026 results on May 12

Organigram Global Inc. will release its second quarter fiscal 2026 results for the period ended March 31, 2026 on Tuesday, May 12, 2026, prior to market open.

Rhea-AI Filing Summary

Organigram Global Inc. will release its second quarter fiscal 2026 results for the period ended March 31, 2026 on Tuesday, May 12, 2026, prior to market open. The company will hold a conference call that day at 8:00 a.m. Eastern Time, with advance registration required through online links.

Organigram describes itself as a leading Canadian cannabis company focused on high-quality products for adult consumers and international partnerships. It operates cultivation, processing, edibles and fulfillment facilities across multiple Canadian provinces and markets a portfolio of brands including Edison, SHRED, Big Bag O’ Buds and others.

Key Figures

Results release date: May 12, 2026 Quarter end date: March 31, 2026 Conference call time: 8:00 a.m. Eastern Time +1 more

4 metrics

Results release date May 12, 2026 Second quarter fiscal 2026 results to be reported before market open

Quarter end date March 31, 2026 Fiscal second quarter 2026 period end

Conference call time 8:00 a.m. Eastern Time Earnings call on May 12, 2026

Webcast replay availability 90 days Replay available on Organigram’s investor site after the call

Key Terms

forward-looking information, Cannabis Act, conference call, webcast, +1 more

5 terms

forward-looking information regulatory

"This news release contains forward-looking information."

Forward-looking information are predictions, plans, estimates or expectations about a company’s future performance, results or events, such as sales forecasts, project timelines, or anticipated costs. It matters to investors because these statements guide expectations but rely on assumptions and uncertain factors—like a weather forecast for a business—so investors should treat them as informed guesses rather than guarantees and consider the risks and possible changes behind the numbers.

Cannabis Act regulatory

"The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations."

A cannabis act is a government law that creates the rules for producing, selling, using, and regulating cannabis products in a given jurisdiction. Think of it like the traffic code for a new industry: it sets who can operate, what safety and labeling standards must be met, and how taxes and licenses are handled — all of which directly affect companies’ costs, revenue potential, and legal risks, so investors watch changes closely.

conference call financial

"The Company will host a conference call to discuss its results with details as follows"

webcast financial

"To access the webcast https://events.q4inc.com/attendee/574618022"

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

annual information form regulatory

"include factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis"

A company's annual information form is a comprehensive regulatory filing that lays out its business description, key assets, risks, legal matters and other background details shareholders need to understand the company’s operations. Think of it as a detailed owner’s manual or dossier that supplements financial statements, helping investors do deeper homework on how the business works and what could affect its future performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Organigram (OGI) report its Q2 fiscal 2026 results?

Organigram will report second quarter fiscal 2026 results on Tuesday, May 12, 2026, for the period ended March 31, 2026. The company plans to release the earnings before market open and follow with a conference call to discuss the results in more detail.

What time is Organigram (OGI)’s Q2 2026 earnings conference call?

Organigram’s Q2 fiscal 2026 earnings conference call is scheduled for 8:00 a.m. Eastern Time on Tuesday, May 12, 2026. Investors must register online in advance to receive unique dial-in details and access codes needed to join the live call and participate.

How can investors access Organigram (OGI)’s Q2 2026 earnings webcast?

Investors can access the Q2 fiscal 2026 earnings webcast via the provided Q4 Inc. attendee link. After registering, participants receive connection details by email. A replay will be posted within 24 hours at Organigram’s investor relations website and remain available for 90 days.

What business does Organigram Global Inc. (OGI) operate?

Organigram Global Inc. operates cannabis cultivation, processing and manufacturing businesses in Canada through wholly owned subsidiaries. It sells adult-use cannabis and cannabinoid beverages under brands like Edison, SHRED and Big Bag O’ Buds and runs facilities in New Brunswick, Quebec, Manitoba and Southwestern Ontario.

Where are Organigram (OGI)’s main cannabis facilities located?

Organigram operates cultivation and processing facilities in Moncton, New Brunswick and Lac Supérieur, Quebec, plus a dedicated edibles facility in Winnipeg, Manitoba. It also runs two cannabis processing facilities in Southwestern Ontario, located in Aylmer and London, supporting extraction, formulation, packaging and national fulfillment activities.

What forward-looking information caution does Organigram (OGI) provide?

Organigram warns that forward-looking information, identified by terms like “plans” or “expects,” involves risks and uncertainties. Actual results may differ materially, and risk factors are described in its annual information form, MD&A and other documents filed on SEDAR+ and furnished to the U.S. Securities and Exchange Commission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 03:28 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-38885

ORGANIGRAM GLOBAL INC.

(Translation of registrant’s name into English)

145 King Street West, Suite 1400

Toronto, Ontario ,Canada M5H 1J8

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ ]           Form 40-F [ X ]

SUBMITTED HEREWITH

Exhibits

99.1 News Release dated May 6, 2026

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ORGANIGRAM GLOBAL INC.

/s/ Greg Guyatt

Greg Guyatt

Chief Financial Officer

Date: May 6, 2026

Organigram to Report Second Quarter Fiscal 2026 Results on May 12th, 2026

TORONTO--(BUSINESS WIRE)-- May 6, 2026 - Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2026 ended March 31, 2026, on Tuesday, May 12, 2026, prior to market open. 

The Company will host a conference call to discuss its results with details as follows: 

Date: Tuesday, May 12, 2026

Time: 8:00 am Eastern Time 

To register for the conference call, please use this link: 

https://events.q4inc.com/analyst/574618022?pwd=FVnom6fM

To ensure you are connected for the full call, we suggest registering a day in advance or at minimum 10 minutes before the start of the call. After registering, a confirmation will be sent through email, including dial in details and unique conference call codes for entry. Registration is open through the live call. 

To access the webcast: 

https://events.q4inc.com/attendee/574618022

Participants will receive their details via email. 

A replay of the webcast will be available within 24 hours after the conclusion of the call at https://www.organigram.ca/investors and will be archived for a period of 90 days following the call. 

About Organigram

Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator and processor. Through its acquisition of Collective Project Limited, Organigram Global participates in the US and Canadian cannabinoid beverages markets.

Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O’ Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class extraction

capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and infused pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations.

Forward-Looking Information

This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variations of such words and phrases or state that certain actions, events, or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information including expectations regarding market performance, involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram Global to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Company’s most recent annual information form, management’s discussion and analysis, and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

For Investor Relations enquiries:

Max Schwartz, Director of Investor Relations

investors@organigram.ca

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EX-99.1 10.4 KB